Cheng et al. treated BC bearing mice with anti-B7-H3 in combination with paclitaxel or anti-PD-1 mAb and concluded B7-H3 inhibition significantly potentiated the tumoricidal effects of either paclitaxel or anti-PD-1 as monotherapies [136]. The gene discussed is CD276; the disease is breast cancer.